Does Rallies show Form 4 insider transactions for PROF?

Yes. Rallies tracks PROF insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is PROF research on Rallies investment advice?

No. Rallies provides research, data, and educational context for PROF. It does not provide personalized investment advice.

PROF (Profound Medical Corp. Common Stock) Stock Analysis - Insider Trades

Profound Medical Corp. Common Stock (PROF) is a publicly traded Healthcare sector company. As of May 21, 2026, PROF trades at $7.04 with a market cap of $250.37M and a P/E ratio of 5.58. PROF moved +2.38% today. Year to date, PROF is -10.94%; over the trailing twelve months it is +38.12%. Its 52-week range spans $3.76 to $9.17. Analyst consensus is buy with an average price target of $11.00. Rallies surfaces PROF's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading PROF stock inside the company?

Recent PROF insider activity includes Menawat Arun Swarup bought 12.03K, Menawat Arun Swarup bought 10.00K, HOFER MICHAEL sold 40.00K, HOFER MICHAEL sold 40.00K, and SVEINSON FREDERICK J bought 500.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

PROF Key Metrics

Key financial metrics for PROF
Metric	Value
Price	$7.04
Market Cap	$250.37M
P/E Ratio	5.58
EPS	$1.24
Dividend Yield	0.00%
52-Week High	$9.17
52-Week Low	$3.76
Volume	3
Avg Volume	0
Revenue (TTM)	$18.81M
Net Income	$-38.90M
Gross Margin	71.08%

Recent PROF Insider Trades

Menawat Arun Swarup bought 12.03K (~$56.89K) on May 16, 2025.
Menawat Arun Swarup bought 10.00K (~$43.26K) on May 15, 2025.
HOFER MICHAEL sold 40.00K (~$6.40K) on Dec 20, 2012.
HOFER MICHAEL sold 40.00K (~$6.20K) on Dec 18, 2012.
SVEINSON FREDERICK J bought 500.00K (~$700) on Jun 19, 2012.

Latest PROF News

Profound Medical Showcases TULSA-PRO at AUA Meeting and PSMA PET Integration — May 14, 2026
Profound Medical AGM Sees 69.8% Turnout, Directors Re-elected with 79.0%–91.5% Support — May 14, 2026
Profound Medical Reports 104% Q1 Revenue Growth, Humana Covers TULSA Procedure — May 7, 2026
Profound Medical Sees Q1 Revenue of $4.85M, Full-Year Revenue Cut 11% — May 6, 2026
Profound Medical Showcases TULSA-PRO in Seven Sessions at SIR Meeting — Apr 29, 2026

PROF Analyst Consensus

2 analysts cover PROF: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $11.00.

Common questions about PROF

Who is trading PROF stock inside the company?: Recent PROF insider activity includes Menawat Arun Swarup bought 12.03K, Menawat Arun Swarup bought 10.00K, HOFER MICHAEL sold 40.00K, HOFER MICHAEL sold 40.00K, and SVEINSON FREDERICK J bought 500.00K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for PROF?: Yes. Rallies tracks PROF insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is PROF research on Rallies investment advice?: No. Rallies provides research, data, and educational context for PROF. It does not provide personalized investment advice.